Evidence of a disturbance of the hypothalamic-pituitary-adrenal axis in polycystic ovary syndrome: Effect of naloxone

Clinical Endocrinology

Volumn 45, Issue 1, 1996, Pages 73-77

  Lanzone, Antonio ^b   Guido, Maurizio ^a   Ciampelli, Mario ^a   Fulghesu, Anna Maria ^a   Pavone, Virginia ^a   Proto, Caterina ^b   Caruso, Alessandro ^a   Mancuso, Salvatore ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b OASI RESEARCH INSTITUTE IRCCS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; HYDROCORTISONE; NALOXONE;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INTRAVENOUS DRUG ADMINISTRATION; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL;

ADOLESCENT; ADRENOCORTICOTROPIC HORMONE; ADULT; FEMALE; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; NALOXONE; NARCOTIC ANTAGONISTS; PITUITARY-ADRENAL SYSTEM; POLYCYSTIC OVARY SYNDROME;

EID: 0029937337     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2265.1996.tb02062.x     Document Type: Article

References (27)

1. Ajers, J.W.T. (1982) Differential response to adrenocorticotropin hormone stimulation in polycystic ovarian disease with high and low dehydroepiandrosterone sulfate levels. Fertility and Sterility, 37, 645-649.
2. DeBold, C.R., Sheldon, W.R., DeCherney, G.S. & Evans, W.S. (1984) Arginine vasopressin potentiates adrenocorticotropin release induced by ovine corticotropin-releasing factor. Journal of Clinical Investigation, 73, 533-538.
3. Delitala, G., Trainer, P.J., Oliva, O. & Grossman, A.B. (1994) Opioid peptide and α-adrenoceptor pathways in the regulation of the pituitary adrenal axis in man. Journal of Endocrinology, 141, 163-168.
4. Estienne, M.J., Kesner, J.S., Barb, C.R., Kraeling, R.R. & Rampacek, C.B. (1988) On the site of action of naloxone-stimulated cortisol secretion in gilts. Life Science, 43, 161-166.
5. Fulghesu, A.M., Lanzone, A., Cucinelli, F., Caruso, A. & Mancuso, S. (1993) Long-term naltrexone treatment reduces the exaggerated insulin secretion in patients with polycystic ovary disease. Obstetrics and Gynecology, 82, 191-197.
6. Givens, J.R., Wiedeman, E., Andersen, R.M. & Kitabchi, A.E. (1980) β-endorphin and β-lipotrophin plasma levels in hirsute women: correlation with body weight. Journal of Clinical Endocrinology and Metabolism, 50, 975-976.
7. Graybeal, M.L. & Fang, V.S. (1985) Phisiological dosing of exogenous ACTH. Acta Endocrinologica (Copenhagen), 108, 401-406.
8. Grossman, A. & Besser, G.M. (1982) Opiates control ACTH through a noradrenergic mechanism. Clinical Endocrinology, 17, 287-290.
9. Grossman, A., Gaillard, R.C., McCartney, P., Rees, L.H. & Besser, G.M. (1982) Opiate modulation of the pituitary adrenal axis: effects of stress and circadian rhythm. Clinical Endocrinology, 17, 279-286.
10. Hockings, G.I., Grice, J.E., Crosbie, G.V., Walters, M.M. & Jackson, R.V. (1992) Naloxone and AVP administration to normal humans results in a synergistic ACTH response which is blunted by nifedipine. Proceedings of the 9th International Congress of Endocrinologists, p. 84.
11. Horrocks, P.M., Franks, S., Hockley, A.D., Rolfe, E.B., Van Noorden, S. & London, D.R. (1982) An ACTH secreting pituitary tumour arising in a patient with congenital adrenal hyperplasia. Clinical Endocrinology, 17, 457-468.
12. Horrocks, P.M., Kandeel, F.R., London, D.R., Butt, W.R., Lynch, S.S. & Holder, G. (1983) ACTH function in women with polycystic ovarian syndrome. Clinical Endocrinology, 19, 143-150.
13. Jackson, R.V., Grice, J.E., Jackson, A.J. & Hockings, G.I. (1990) Naloxone induced ACTH release in man is inhibited by clonidine. Clinical Experimental Pharmacology and Physiology, 17, 179-184.
14. Kandeel, F.R., London, D.R., Butt, W.R., Davila, N., Rudd, B.T. & Sadeghian, S. (1980) Adrenal function in subgroups of the PCO syndrome assessed by a long ACTH test. Clinical Endocrinology, 13, 601-612.
15. Kase, N., Kowald, J., Perloff, W. & Soffer, L.L. (1963) In vitro production of androgens by a virilizing adrenal adenoma and associated polycystic ovaries. Acta Endocrinologica (Copenhagen), 44, 15-19.
16. Laatikainen, T.J. (1991) Corticotropin-releasing hormone and opioid peptides in reproduction and stress. Annals of Medicine, 23, 489-495.
17. Lanzone, A., Fulghesu, A.M., Guido, M., Ciampelli, M., Caruso, A. & Mancuso, S. (1994) Differential androgen response to adrenocorticotrophin hormone stimulation and effect of opioid antagonist on insulin secretion in polycystic ovarian syndrome. Human Reproduction, 9, 2242-2246.
18. Lanzone, A., Petraglia, F., Fulghesu, A.M., Ciampelli, M., Caruso, A. & Mancuso, S. (1995) Corticotropin-releasing hormone induces an exaggerated response of adrenocorticotropic hormone and cortisol in polycystic ovary syndrome. Fertility and Sterility. 63, 1195-1199.
19. Lucky, A.W., Rosenfield, R.L., McGuire, S., Rudy, S. & Helke, S. (1986) Adrenal androgen hyperresponsiveness to adrenocorticotropin in women with acne and/or hirsutism: adrenal enzyme defects and exaggerated adrenarche. Journal of Clinical Endocrinology and Metabolism, 62, 840-848.
20. Lymangrover, J.R., Dokas, L.A., Kong, A., Martin, R. & Saffran, M. (1981) Naloxone has a direct effect on the adrenal cortex. Journal of Clinical Endocrinology and Metabolism, 109, 1132-1137.
21. New, M.I., Lorenzen, F., Lerner, A.J., Kohn, B., Oberfield, S.E., Pollack, M.S., Dupont, B., Stoner, E., Levy, D.J., Pang, S. & Levine, L.S. (1983) Genotyping steroid 21-hydroxylase deficiency: hormonal reference data. Journal of Clinical Endocrinology and Metabolism, 57, 320-326.
22. Nikolarakis, K., Pfeiffer, A., Stalla, G.K. & Herz, A. (1987) The role of CRF in the release of ACTH by opiate agonists and antagonists in rats. Brain Research, 421, 373-376.
23. Pasquali, R., Cantobelli, S., Casimirri, F., Capelli, M., Bortoluzzi, L., Flamia, R., Labate Morselli, A.M. & Barbara, L. (1993) The hypothalamic-pituitary-adrenal axis in obese women with different patterns of body fat distribution. Journal of Clinical Endocrinology and Metabolism, 77, 341-346.
24. Taylor, T., Dluhy, R.G. & Williams, G.H. (1983) β-endorphin suppresses adrenocorticotropin and cortisol levels in normal human subjects. Journal of Clinical Endocrinology and Metablism, 57, 1292-1296.
25. Volavka, J., Cho, D., Mallya, A. & Bauman, J. (1979) Naloxone increases ACTH and cortisol levels in man. New England Journal of Medicine, 300, 1056-1057.
26. Wortsman, J., Weherberger, W.B., Gavin, J.R. & Allen, J.P. (1984) Elevated levels of plasma β-endorphin and γ3-melanocyte stimulating hormone in the polycystic ovary syndrome. Obstetrics and Gynecology, 63, 630-634.
27. Yen, S.S.C. (1980) Polycystic ovary syndrome. Clinical Endocrinology, 12, 177-208.